Lentivirus construction and transfection 31
Lentiviruses encoding short hairpin (sh)RNAs were produced using pLKO.1-puro and 32 pLKO.1-neo (Genechem, Shanghai, China and DesignGene, Shanghai, China) and 33 were denoted as "shCAMSAP2," "shEB1," "shTrio," "shHDAC6," and "shc-Jun." 34
Plasmid construction 45
Plasmids were constructed as previously described [1, 2] . All primers used are listed in 46 Table S8 . Briefly, a HDAC6 promoter region (-1690/+136) was amplified from 47 human genomic DNA using forward and reverse primers with MluI and XhoI sites at 48 the 3' and 5' end, respectively. The amplification product was cloned into MluI-and 49
XhoI-digested pGL3-Basic vector (Promega, Madison, WI). Constructs containing a 50 deletion in the 5'-flanking region of the HDAC6 promoter, (-1384/+136) HDAC6, (-51 469/+136) HDAC6, and (-199/+136) HDAC6, were constructed using the (-52 1690/+136) HDAC6 construct as the template. The QuikChange II Site-Directed 53
Mutagenesis Kit (Stratagene, CA, USA) was utilized to mutate putative c-Jun binding 54 sites in the HDAC6 promoter region. The pSpCas9(BB)-2A-Puro (PX459, Addgene) 55 vector that was used for the CRISPR/Cas9 knockout and the targeting sequence of 20 56 nucleotides was cloned into the vector (Qijing Biological Technology, Wuhan China). 57
The sequence of sgRNA was designed as previously described [3] . The vectors
Microtubule fractionation assay 89
Microtubule fractionation assays were performed as described previously [5] , with 90 slight modifications. Cells were washed with PBS at 37°C and incubated with 91 microtubule-stabilizing buffer (100 mM PIPES, pH 6.8, 2 mM EGTA, 1 mM MgCl 2 ) 92 supplemented with protease inhibitor cocktail and 0.5% NP-40 at 37°C for 15 min. 93
Lysates were centrifuged at 1,000g for 10 min. The pelleted cells were lysed with 94 sodium dodecyl sulfate (SDS) lysis buffer. The cell pellet and supernatant were mixed 95 with sample buffer, boiled, and subjected to SDS-polyacrylamide gel electrophoresis 96 (PAGE). 97
98
Microtubule repolymerization assay 99 per the manufacturer's protocol. Briefly, cells transfected with the indicated plasmids 111 were lysed; the lysates were centrifuged at maximum speed for 1 min. Luciferase 112 activity was measured using a TD20/20 Luminometer (Turner Biosystems, USA) and 113 was normalized to Renilla luciferase activity. 114 115
Co-immunoprecipitation assay 116
Co-immunoprecipitation was performed as described previously [6] . Briefly, cells 117 were lysed on ice with lysis buffer containing 1% NP-40 (Promoter, China) for 30 118 min. The lysates were centrifuged at 12,000g for 15 min. The supernatants were 119 incubated with Protein G-conjugated Sepharose beads (Santa Cruz Biotechnology, TX, 120 USA) and the appropriate antibodies at 4°C overnight. Immunoprecipitates were 121 washed thrice with lysis buffer and separated by SDS-PAGE. The antibodies used are 122 listed in Table S9 . 123 Otsu, Japan) on ABI StepOne system (Applied Biosystems, Carlsbad, CA, USA). The 141 thermal cyclers were as follows: 40 cycles of 95°C for 30 s, 95°C for 5 s, and 60°C 142 for 30 s. The 2 -ΔΔCt method was used to determine fold differences between samples. 143 144
Western blotting 145
Western blot analyses were conducted as previously described [1, 2] . Antibodies are 146 listed in Table S9 . 147 148
Tissue microarray analysis and immunohistochemistry (IHC) 149
Tissue microarrays were constructed as described previously [1, 2] . For IHC, 150 paraffin-embedded tissues were cut into 4-µm -thick sections. The sections were 151 deparaffinized in dimethylbenzene, subjected to gradient alcohol dehydration, treated 152 with 3% H 2 O 2 to block endogenous peroxidase, and incubated with primary 153 antibodies overnight. Then, the sections were incubated with the secondary antibody at room temperature for 30 min. Immunoreactivity was visualized with 155 diaminobenzidine and the sections were counterstained with hematoxylin. 156
Antibodies are listed in Table S9 . 157 158 IHC was evaluated by two independent observers who were blinded to the clinical 159 and outcome data. The percentage of positive cells was scored on a scale of 0 to 4: 0 160 (negative), 1 (1%-25%), 2 (26%-50%), 3 (51%-75%), or 4 (76%-100%). The 161 staining intensity was graded on a scale of 0 to 3: 0 (negative), 1 (weak), 2 (medium), 162 or 3 (strong). Final immuno-activity scores were calculated by multiplying the above 163 two scores, with final scores ranging from 0 to 12. Immuno-activity was considered 164 positive if the final score was 4, or negative if it was <4. 165 166
Anchorage-dependent tumor growth assay 167
Eight-hundred cells were seeded into a 6-well cell-culture plate and cultivated in 168 DMEM supplemented with 10% FBS at 37°C in a humidified atmosphere containing 169 5% CO 2 for 14 days. After removing the medium and washing twice with PBS, the 170 cells were fixed with 4% paraformaldehyde at room temperature for 15 min and 171 stained with crystal violet for another 15 min. The plates were imaged using a camera. 172 
